IAG Wealth Partners’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$1.48K 527
2024
Q3
$1.48K Hold
100
﹤0.01% 455
2024
Q2
$1.39K Hold
100
﹤0.01% 464
2024
Q1
$1.57K Hold
100
﹤0.01% 410
2023
Q4
$1.62K Hold
100
﹤0.01% 391
2023
Q3
$1.23K Hold
100
﹤0.01% 411
2023
Q2
$1.61K Hold
100
﹤0.01% 408
2023
Q1
$1.74K Hold
100
﹤0.01% 412
2022
Q4
$924 Hold
100
﹤0.01% 409
2022
Q3
$1K Hold
100
﹤0.01% 415
2022
Q2
$1K Hold
100
﹤0.01% 414
2022
Q1
$1K Hold
100
﹤0.01% 425
2021
Q4
$3K Hold
100
﹤0.01% 368
2021
Q3
$5K Hold
100
﹤0.01% 333
2021
Q2
$5K Hold
100
﹤0.01% 320
2021
Q1
$5K Sell
100
-100
-50% -$5.21K ﹤0.01% 314
2020
Q4
$11K Hold
200
﹤0.01% 233
2020
Q3
$8K Hold
200
﹤0.01% 250
2020
Q2
$7K Hold
200
﹤0.01% 267
2020
Q1
$6K Hold
200
﹤0.01% 263
2019
Q4
$6K Buy
+200
New +$4.76K ﹤0.01% 297

Other funds holding NEO

IAG Wealth Partners's NEO Position: Q4 2024 in Review

IAG Wealth Partners sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 100 shares — an estimated $1.48K sold.

IAG Wealth Partners first reported a position in NEO in Q4 2019 and held it in 20 quarters. The position peaked at $11K in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • IAG Wealth Partners reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • IAG Wealth Partners sold 100 NeoGenomics shares in Q4 2024, an estimated $1.48K.
  • IAG Wealth Partners first reported a position in NeoGenomics in Q4 2019 and held it in 20 quarters.
  • IAG Wealth Partners's NeoGenomics position peaked at $11K in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on IAG Wealth Partners's 13F filing for Q4 2024, filed 10 Feb 2025.